{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:10:35Z","timestamp":1760771435888,"version":"build-2065373602"},"reference-count":32,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"published-print":{"date-parts":[[1997,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the platelet activation in different modes of pacing in patients implanted with dual chamber rate adaptive pacemaker (DDDR) for bradyarrhythmias, and to explore the possible underlying mechanism of the higher thromboembolic incidence in single chamber ventricular rate adaptive (VVIR) pacing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Platelet activation was determined in chronically paced patients during three different pacing modes (VVIR, DDD, and DDDR) in a randomised crossover fashion.<\/jats:p>\n                  <jats:p>\n                     <jats:italic>Setting<\/jats:italic>\u2014Pacemaker clinic at a university teaching hospital.<\/jats:p>\n                  <jats:p>\n                     <jats:italic>Patients<\/jats:italic>\u201415 patients with complete heart block, mean (SD) age 63 (10) years, and 12 patients with sick sinus syndrome, mean age 68 (9) years, implanted with DDDR pacemakers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Platelet activation was assessed by measuring the plasma concentrations of platelet factor 4 (PF4) and \u03b2 thromboglobulin using an enzyme linked immunosorbent assay (<jats:sc>elisa<\/jats:sc>). Mean log plasma PF4 and \u03b2 thromboglobulin values were compared in paced patients during different pacing modes and with control.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with controls, patients paced in DDDR, DDD, and VVIR modes had higher mean log plasma concentrations of PF4 (0.90 (0.32), 0.92 (0.29), and 1.12 (0.33)<jats:italic>v<\/jats:italic> 0.61 (0.29) log IU\/ml, all p\u2009&lt;\u20090.05, respectively) and \u03b2 thromboglobulin (1.55 (0.20), 1.59 (0.16), and 1.71 (0.18)<jats:italic>v<\/jats:italic> 1.40 (0.12) log IU\/ml, all p\u2009&lt;\u20090.05, respectively). In paced patients, VVIR pacing was associated with higher plasma concentrations of PF4 and \u03b2 thromboglobulin than either DDDR or DDD pacing (all p\u2009&lt;\u20090.05). There was no significant difference in plasma PF4 and \u03b2 thromboglobulin between patients with complete heart block and sick sinus syndrome in the corresponding pacing mode. Holter monitoring showed no difference in mean pacing rate and occurrence of cardiac arrhythmias to account for the increased platelet activation during VVIR pacing. There was no relation between the percentage of ventricular pacing on Holter during DDDR, DDD, and VVIR modes and the log mean plasma concentrations of PF4 (<jats:italic>r = <\/jats:italic>0.002, 0.001, and 0.001, respectively, all p\u2009&gt;\u20090.05) and \u03b2 thromboglobulin (<jats:italic>r <\/jats:italic>= 0.007, 0.01, and 0.001, respectively, all p\u2009&gt;\u20090.05).<\/jats:p>\n                  <jats:p>\n                     <jats:italic>Conclusions<\/jats:italic>\u2014Single chamber ventricular pacing was associated with enhanced spontaneous systemic platelet activation compared with physiological dual chamber pacing. This was related to the loss of atrioventricular synchrony rather than to the underlying cause of bradycardia, lack of rate response, or coexisting arrhythmia. This abnormality may be associated with increased thromboembolism and was correctible by an appropriate pacing mode prescription and possibly antiplatelet treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/hrt.78.4.358","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T15:31:45Z","timestamp":1413991905000},"page":"358-363","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients"],"prefix":"10.1136","volume":"78","author":[{"given":"Chu-Pak","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1997,10,1]]},"reference":[{"key":"2025101723530435000_78.4.358.1","first-page":"245","article-title":"The use of an intracardiac pacemaker in the correction of total heart block.","volume":"9","author":"Furman","year":"1958","journal-title":"Surg Forum"},{"key":"2025101723530435000_78.4.358.2","first-page":"261","article-title":"Sinoatrial disorder; \u201cthe sick sinus\u201d syndrome. Experience with implanted cardiac pacemaker.","volume":"19","author":"Kaul","year":"1978","journal-title":"J Cardiovasc Surg"},{"key":"2025101723530435000_78.4.358.3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1979.tb13486.x","article-title":"Sick sinus syndrome treated with permanent pacemaker in 109 patients.","volume":"206","author":"Breivik","year":"1979","journal-title":"Acta Med Scand"},{"key":"2025101723530435000_78.4.358.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(82)90162-4"},{"key":"2025101723530435000_78.4.358.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1986.tb06678.x"},{"key":"2025101723530435000_78.4.358.6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90244-X"},{"key":"2025101723530435000_78.4.358.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1988.tb06292.x"},{"key":"2025101723530435000_78.4.358.8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/0735-1097(92)90616-U","article-title":"Deleterious effects of long term single chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual chamber pacing.","volume":"19","author":"Hesselson","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2025101723530435000_78.4.358.9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.CIR.88.3.1045","article-title":"Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: relevance of clinical characteristics and pacing modalities.","volume":"88","author":"Sgarboss","year":"1993","journal-title":"Circulation"},{"key":"2025101723530435000_78.4.358.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90347-6"},{"key":"2025101723530435000_78.4.358.11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.2830100407","article-title":"Human platelet factor IV: preparation from outdated platelet concentrates and application in cerebral vascular disease.","volume":"10","author":"Levine","year":"1981","journal-title":"Am J Hematol"},{"key":"2025101723530435000_78.4.358.12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(83)90511-1","article-title":"Prognostic value of beta-thromboglobulin in patients with transient cerebral ischemia.","volume":"ii","author":"Stewart","year":"1983","journal-title":"Lancet"},{"key":"2025101723530435000_78.4.358.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301808"},{"key":"2025101723530435000_78.4.358.14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V58.3.607.607","article-title":"Studies of human platelet alpha granule release in vivo.","volume":"58","author":"Files","year":"1981","journal-title":"Blood"},{"key":"2025101723530435000_78.4.358.15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1996.331661000.x"},{"key":"2025101723530435000_78.4.358.16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V57.2.199.199","article-title":"Plasma levels of \u03b2-thromboglobulin and platelet factors 4 as indices of platelet activation in vivo.","volume":"57","author":"Kaplan","year":"1981","journal-title":"Blood"},{"key":"2025101723530435000_78.4.358.17","unstructured":"Kaplan KL (1994) Laboratory marker of platelet activation. in Hemostasis and thrombosis: basic principles and clinical practice, eds Colman RW Hirsh J Marder VJ Salzman EW (Lippincott, Philadelphia), 3rd ed. pp 1180\u20131181."},{"key":"2025101723530435000_78.4.358.18","first-page":"126","article-title":"Toward physiological stimulation in sinus node disease.","volume":"2","author":"Sutton","year":"1994","journal-title":"Eur J Cardiac Pacing Electrophysiol"},{"key":"2025101723530435000_78.4.358.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb01572.x"},{"key":"2025101723530435000_78.4.358.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1991.tb05086.x"},{"key":"2025101723530435000_78.4.358.21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(74)91131-3","article-title":"A new method for quantitative detection of platelet aggregates in patients with arterial insufficiency.","volume":"ii","author":"Wu","year":"1974","journal-title":"Lancet"},{"key":"2025101723530435000_78.4.358.22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0002-9149(79)90075-4","article-title":"Platelet function studies in coronary artery disease. V. Evidence of enhanced platelet micro thrombus formation activity in acute myocardial infarction.","volume":"43","author":"Mehta","year":"1977","journal-title":"Am J Cardiol"},{"key":"2025101723530435000_78.4.358.23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(77)92774-X","article-title":"Platelet activation in acute cerebral ischaemia.","volume":"i","author":"Dougherty","year":"1977","journal-title":"Lancet"},{"key":"2025101723530435000_78.4.358.24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.STR.16.4.643","article-title":"Enhanced in-vivo platelet activation in subtypes of ischemic stroke.","volume":"16","author":"Shah","year":"1985","journal-title":"Stroke"},{"key":"2025101723530435000_78.4.358.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(73)80053-0"},{"key":"2025101723530435000_78.4.358.26","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90239-0"},{"key":"2025101723530435000_78.4.358.27","first-page":"1194","article-title":"Platelet activation in unstable coronary disease.","volume":"313","author":"FitzGerald","year":"1986","journal-title":"N Engl J Med"},{"key":"2025101723530435000_78.4.358.28","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","article-title":"Platelet hyperreactivity and prognosis in survivors of myocardial infarction.","volume":"323","author":"Trip","year":"1990","journal-title":"N Engl J Med"},{"key":"2025101723530435000_78.4.358.29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1055\/s-0038-1649852","article-title":"Correlation of specific platelet activation markers with carotid artery wall thickness.","volume":"74","author":"Ghaddar","year":"1995","journal-title":"Thromb Haemost"},{"key":"2025101723530435000_78.4.358.30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet therapy.","volume":"296","year":"1988","journal-title":"BMJ"},{"key":"2025101723530435000_78.4.358.31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1536\/ihj.27.481","article-title":"Plasma \u03b2-thromboglobulin and platelet factor 4 concentration in patients with atrial fibrillation.","volume":"27","author":"Yamauchi","year":"1986","journal-title":"Jpn Heart J"},{"key":"2025101723530435000_78.4.358.32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/oxfordjournals.eurheartj.a060413","article-title":"Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life.","volume":"15","author":"Lau","year":"1994","journal-title":"Eur Heart J"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.78.4.358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:53:16Z","timestamp":1760770396000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.78.4.358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10,1]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1997,10,1]]},"published-print":{"date-parts":[[1997,10,1]]}},"alternative-id":["10.1136\/hrt.78.4.358"],"URL":"https:\/\/doi.org\/10.1136\/hrt.78.4.358","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[1997,10,1]]}}}